ÂÜÀòÂÒÂ×

Erin Erginer has a diverse work experience, with their most recent position being as the Director of Product at Pinnacle 21 since June 2021. Prior to that, they worked at GSK, starting in December 2018 as a Senior Manager, Vendor Data Acquisition. In this role, they led a team responsible for acquiring complex biomarker, imaging, and eCOA data. Erin successfully brokered a proposal that reduced team impact by 80% during major layoffs and spearheaded collaboration with various project team members. Erin also worked as an SDTM Data Analyst at GSK from June 2018 to December 2018, where they oversaw case report tabulation packages for FDA submission and created RACI and process flow diagrams for new business initiatives.

Before joining GSK, Erin had roles at DOCS, starting as a Clinical Trials Data Manager in October 2012 and later transitioning to a Manager External Data Management position in October 2013. Erin worked in these positions until June 2018. Erin also worked as a Research Technician II at Duke University from May 2010 to March 2012, and as a Cytopathology Technician at Greensboro Pathology Associates from May 2009 to May 2010. Starting their career, they worked as an Office Assistant at Erie Women's Health Partners from April 2002 to April 2009.

Erin Erginer's education history includes a Bachelor of Science (B.S.) degree in Biology, General from Penn State University, completed between 2005 and 2008. In 2012 and 2013, Erginer pursued a Certificate in Clinical Trials Database Management at Durham Technical Community College. Erginer also obtained a Certificate in Measuring and Improving Business Performance from Cornell University in 2017. In addition, Erginer holds a High School Diploma from Cathedral Preparatory School & Villa Maria Academy, although the specific years of completion are not provided.